The 63rd Annual Meeting of the American Academy of Neurology (AAN) was held in April of this year. This report highlights a selection of studies reporting the incidence of adverse events associated with different therapies, the adverse events associated with multiple sclerosis therapies and concomitant therapies that may be associated with exacerbation of disease symptoms. …
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten